These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1283391

  • 21. [Clinical pharmacology of hydroxyurea].
    Góra-Tybor J, Robak T.
    Acta Haematol Pol; 1995; 26(1):39-45. PubMed ID: 7747561
    [Abstract] [Full Text] [Related]

  • 22. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R.
    Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
    [Abstract] [Full Text] [Related]

  • 23. Levels of fetal hemoglobin necessary for treatment of sickle cell disease.
    Noguchi CT, Rodgers GP, Serjeant G, Schechter AN.
    N Engl J Med; 1988 Jan 14; 318(2):96-9. PubMed ID: 2447498
    [No Abstract] [Full Text] [Related]

  • 24. Use of hydroxyurea in children with sickle cell disease: what comes next?
    Ohene-Frempong K, Smith-Whitley K.
    Semin Hematol; 1997 Jul 14; 34(3 Suppl 3):30-41. PubMed ID: 9317199
    [Abstract] [Full Text] [Related]

  • 25. Pharmacologic manipulation of fetal hemoglobin. Update on clinical trials with hydroxyurea.
    Dover GJ.
    Ann N Y Acad Sci; 1990 Jul 14; 612():184-90. PubMed ID: 1705407
    [No Abstract] [Full Text] [Related]

  • 26. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
    Vicari P, Barretto de Mello A, Figueiredo MS.
    Am J Hematol; 2005 Mar 14; 78(3):243-4. PubMed ID: 15726590
    [Abstract] [Full Text] [Related]

  • 27. Hydroxyurea therapy for diverse pediatric populations with sickle cell disease.
    Rogers ZR.
    Semin Hematol; 1997 Jul 14; 34(3 Suppl 3):42-7. PubMed ID: 9317200
    [Abstract] [Full Text] [Related]

  • 28. Hydroxyurea and new agents for the treatment of sickle cell disease.
    Rodgers GP.
    Clin Adv Hematol Oncol; 2004 Nov 14; 2(11):713-5. PubMed ID: 16163257
    [No Abstract] [Full Text] [Related]

  • 29. The effect of increased fetal hemoglobin production on the frequency of vaso-occlusive crisis in sickle cell disease.
    Dover GJ, Charache S.
    Prog Clin Biol Res; 1987 Nov 14; 240():277-85. PubMed ID: 2441416
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacological induction of foetal haemoglobin synthesis in sickle-cell disease.
    Saleh AW, Hillen HF.
    Neth J Med; 1997 Nov 14; 51(5):169-78. PubMed ID: 9455096
    [Abstract] [Full Text] [Related]

  • 31. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
    Charache S.
    Semin Hematol; 1997 Jul 14; 34(3 Suppl 3):15-21. PubMed ID: 9317197
    [Abstract] [Full Text] [Related]

  • 32. DNA hypomethylation therapies and hemoglobin disorders. [An interview with Hassana Fathallah by H&O].
    Fathallah H.
    Clin Adv Hematol Oncol; 2008 Nov 14; 6(11):806-8. PubMed ID: 19194363
    [No Abstract] [Full Text] [Related]

  • 33. Sickle cell anemia--basic research reaches the clinic.
    Schechter AN, Rodgers GP.
    N Engl J Med; 1995 May 18; 332(20):1372-4. PubMed ID: 7536300
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacological modification of hemoglobin F expression in sickle cell anemia: an update on hydroxyurea studies.
    Charache S.
    Experientia; 1993 Feb 15; 49(2):126-32. PubMed ID: 7680002
    [Abstract] [Full Text] [Related]

  • 35. Determinants of fetal hemoglobin response to hydroxyurea.
    Steinberg MH.
    Semin Hematol; 1997 Jul 15; 34(3 Suppl 3):8-14. PubMed ID: 9317196
    [Abstract] [Full Text] [Related]

  • 36. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
    Galanello R, Veith R, Papayannopoulou T, Stamatoyannopoulos G.
    Prog Clin Biol Res; 1985 Jul 15; 191():433-45. PubMed ID: 2413479
    [No Abstract] [Full Text] [Related]

  • 37. [Hydroxyurea and other agents stimulating synthesis of fetal hemoglobin].
    de Montalembert M.
    Pathol Biol (Paris); 1999 Jan 15; 47(1):55-8. PubMed ID: 10081780
    [Abstract] [Full Text] [Related]

  • 38. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP.
    Semin Hematol; 1997 Jul 15; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.